Using Genetic Methods to Get Insight Into Human Complex Traits
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Document Title: the Determination of the Physical Characteristics of an Individual from Biological Stains Author: Jack Ballantyne, Ph.D
The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains Author: Jack Ballantyne, Ph.D. Document No.: 223978 Date Received: September 2008 Award Number: 2005-MU-BX-K075 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. THE DETERMINATION OF THE PHYSICAL CHARACTERISTICS OF AN INDIVIDUAL FROM BIOLOGICAL STAINS FINAL REPORT January 16 2007 Department of Justice, National Institute of Justcie Award Number: 2005-MU-BX-K075 (1 September 2005- 31 December 2007) Principal Investigator: Jack Ballantyne, Ph.D. Associate Professor Department of Chemistry Associate Director for Research National Center for Forensic Science 4000 Central Boulevard, Bldg#5 University of Central Florida Orlando, FL 32816-2366 Phone: (407) 823 4440 Fax: (407) 823 2252 e-mail: [email protected] This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. EXECUTIVE SUMMARY 1. It is now a matter of routine for the forensic scientist to obtain the genetic profile of an individual from DNA recovered from a biological stain deposited at a crime scene. -
Functional Annotation of the Transcriptome of the Pig, Sus Scrofa, Based Upon Network Analysis of an Rnaseq Transcriptional Atlas
Edinburgh Research Explorer Functional annotation of the transcriptome of the pig, Sus scrofa, based upon network analysis of an RNAseq transcriptional atlas Citation for published version: Summers, K, Bush, S, Wu, C, Su, A, Muriuki, C, Clark, E, Finlayson, H, Eory, L, Waddell, L, Talbot, R, Archibald, A & Hume, D 2020, 'Functional annotation of the transcriptome of the pig, Sus scrofa, based upon network analysis of an RNAseq transcriptional atlas', Frontiers in genetics. https://doi.org/10.3389/fgene.2019.01355 Digital Object Identifier (DOI): 10.3389/fgene.2019.01355 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Frontiers in genetics General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 01. Oct. 2021 ORIGINAL RESEARCH published: 14 February 2020 doi: 10.3389/fgene.2019.01355 Functional Annotation of the Transcriptome of the Pig, Sus scrofa, Based Upon Network Analysis of an RNAseq Transcriptional Atlas Kim M. Summers 1*†, Stephen J. Bush 2†, Chunlei Wu 3, Andrew I. -
The Genome-Wide Impact of Trisomy 21 on DNA Methylation and Its Implications for Hematopoiesis
ARTICLE https://doi.org/10.1038/s41467-021-21064-z OPEN The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis Ivo S. Muskens1,2, Shaobo Li 1,2,13, Thomas Jackson3,13, Natalina Elliot3,13, Helen M. Hansen4, Swe Swe Myint1,2, Priyatama Pandey1,2, Jeremy M. Schraw5,6, Ritu Roy7, Joaquin Anguiano4, Katerina Goudevenou3, Kimberly D. Siegmund 8, Philip J. Lupo5,6, Marella F. T. R. de Bruijn 9, Kyle M. Walsh 10,11, Paresh Vyas 9, Xiaomei Ma12, Anindita Roy 3, Irene Roberts3, Joseph L. Wiemels1,2 & ✉ Adam J. de Smith 1,2 1234567890():,; Down syndrome is associated with genome-wide perturbation of gene expression, which may be mediated by epigenetic changes. We perform an epigenome-wide association study on neonatal bloodspots comparing 196 newborns with Down syndrome and 439 newborns without Down syndrome, adjusting for cell-type heterogeneity, which identifies 652 epigenome-wide significant CpGs (P < 7.67 × 10−8) and 1,052 differentially methylated regions. Differential methylation at promoter/enhancer regions correlates with gene expression changes in Down syndrome versus non-Down syndrome fetal liver hematopoietic stem/progenitor cells (P < 0.0001). The top two differentially methylated regions overlap RUNX1 and FLI1, both important regulators of megakaryopoiesis and hematopoietic devel- opment, with significant hypermethylation at promoter regions of these two genes. Excluding Down syndrome newborns harboring preleukemic GATA1 mutations (N = 30), identified by targeted sequencing, has minimal impact on the epigenome-wide association study results. Down syndrome has profound, genome-wide effects on DNA methylation in hematopoietic cells in early life, which may contribute to the high frequency of hematological problems, including leukemia, in children with Down syndrome. -
Identification of Genes Potentially Involved in Bone Metastasis by Genome-Wide Gene Expression Profile Analysis of Non-Small Cell Lung Cancer in Mice
INTERNATIONAL JOURNAL OF ONCOLOGY 40: 1455-1469, 2012 Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice LE TAN DAT1,2, TAISUKE MATSUO1, TETSURO YOSHIMARU1, SOJI KAKIUCHI2, HISATSUGU GOTO2, MASAKI HANIBUCHI2, TAKUYA KURAMOTO1, YASUHIKO NISHIOKA2, SABURO SONE2 and TOYOMASA KATAGIRI1 1Division of Genome Medicine, Institute for Genome Research, The University of Tokushima; 2Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan Received October 26, 2011; Accepted December 22, 2011 DOI: 10.3892/ijo.2012.1348 Abstract. Lung cancer is commonly associated with multi- of this disease is predominantly due to the difficulty of early organ metastasis, and the bone is a frequent metastatic site diagnosis and the highly metastatic potential of lung cancer. In for lung cancer. However, the molecular mechanism of organ- many cases, metastases to multiple organs have already devel- specific metastasis remains poorly understood. To elucidate this oped by the time of diagnosis (2-4). In particular, ~30-40% of issue, we analyzed in this study genome-wide gene expression patients with advanced lung cancer will develop bone metas- profiles of 15 metastatic lesions from three organs (bone, lung tases in the course of their disease, resulting in a significant and liver) in a mouse model with multi-organ metastasis prop- negative impact on both morbidity and survival (3-5). Currently erties of human non-small cell lung cancer cells (ACC-LC319/ no curative therapy exists for bone metastasis, and clinical bone2), using a combination of laser-microbeam microdissec- management is generally palliative (3,6,7).